Clinithink Completes Series A Funding

Clinithink, a London, UK-based healthcare software company has completed a multi-million dollar Series A funding.

The round was led by Vanguard Atlantic (read here), with participation Finance Wales and existing investors.

The company intends to use the funding for ongoing development of its technology, establishment of its US operation, as well as for its UK-based R&D function.

Led by CEO Chris Tackaberry, Clinithink has developed cloud-based text processing capability that can be used to support data analytics, coding and decision support in healthcare applications. Its patent-pending Clinical Language Indexing software (CLiX) uses Natural Language Processing (NLP) to construct coded output from physicians’ notes using industry data standards (ICD-9, ICD-10, and SNOMED CT).
CLiX allows third party resellers targeting healthcare providers, insurers, pharma companies and other aggregators of clinical data to enable their customers to gain insights into large volumes of rich, unstructured textual data.



Join the discussion